ArticleCell reports2014

A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.

Annabelle Lewis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.